沙丁胺醇与异丙托溴胺联合雾化吸入治疗支气管哮喘急性发作的临床效果观察

目的：探讨沙丁胺醇与异丙托溴胺联合雾化吸入治疗支气管哮喘急性发作的临床疗效。方法选取2011年12月～2013年12月在我院进行治疗的82例支气管哮喘急性发作患者，随机分为观察组和对照组，对照组给予常规治疗和沙丁胺醇雾化吸入治疗，观察组在对照组治疗的基础上，加用异丙托溴胺雾化吸入进行治疗，比较两组的疗效。结果观察组显效率为61.90％，总有效率为95.24％，对照组显效率为30.00％，总有效率为77.50％，两组差异有统计学意义（P＜0.05）。结论沙丁胺醇与异丙托溴胺联合雾化吸入治疗支气管哮喘急性发作，可显著增加治疗效果。

The clinical effect of salbutamol and ipratropium bromide combined with aerosol inhalation in treatment of acute attack of bronchial asthma

Objective To investigate the clinical therapeutic effect of the salbutamol and ipratropium bromide combined with aerosol inhalation in treatment of acute attack of bronchial asthma. Methods We Selected 82 cases of bronchial asthma patients with acute onset, who was in our hospital for treatment from December 2011 to December 2013. They were randomly divided into the observation group and the control group, the control group were given routine treatment and salbutamol atomization inhalation treatment. Added the ipratropium bromide aerosol inhalation treatment to the treatment of the control group in observation group. Compared the two groups of the treatment efficacy. Results In the observation group, the significant effective rate was 61.90%, the total effective rate was 95.24%, in the control group, the significant effective rate was 30%, the total effective rate was 77.50%. There was significant difference between the two groups （P 〈0.05）. Conclusion Salbutamol and ipratropium bromide combined atomization inhalation in the treatment of acute attack of bronchial asthma, can significantly increase the therapeutic effect.